Importantly, the authors proposed that the levels of sAPPα were so crucial that an imbalance could stimulate amyloidogenic APP processing,54 concluding that sAPPα mimetics are a potential therapeutic target for the treatment of AD. This evidence concerns the gene APP and Alzheimer disease.